• Phosphatase Inhibitor Cocktail: Optimizing Stem Cell Phospho

  2026-06-30

  Explore how the Phosphatase Inhibitor Cocktail preserves protein phosphorylation integrity in advanced stem cell and telomerase research. This in-depth analysis reveals unique assay strategies, mechanistic insights, and protocol nuances for high-fidelity phosphoproteomic results.

• Metronidazole: Applied OAT3 Inhibition for Translational Res

  2026-06-29

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) uniquely enables both anaerobic bacteria targeting and precise modulation of organic anion transporters in advanced research workflows. This article translates the latest mechanistic insights and protocol enhancements into actionable strategies for maximizing reproducibility and data quality in drug interaction, microbiota, and immune studies.

• EdU Imaging Kits: Advanced 5-ethynyl-2'-deoxyuridine Cell Pr

  2026-06-29

  EdU Imaging Kits (HF488) from APExBIO offer a robust, high-sensitivity platform for DNA synthesis measurement in proliferating cells, outperforming traditional BrdU-based methods. This article explores experimental workflows, real-world troubleshooting, and the integration of EdU technology in translational oncology, including insights from a landmark ferroptosis study.

• Trifluoperazine 2HCl: Advanced Protocols for Dopamine D2 and

  2026-06-28

  Discover how Trifluoperazine 2HCl enables precise dopamine D2 receptor inhibition while unlocking new frontiers in macrophage immunity research. This article offers in-depth protocols, mechanistic insights, and practical guidance not found elsewhere.

• Synergistic Photothermal-CD47 Blockade in OSCC Immunotherapy

  2026-06-27

  The reference study demonstrates that combining photothermal therapy (PTT) with CD47 immune checkpoint blockade in oral squamous cell carcinoma (OSCC) overcomes key barriers to macrophage-driven tumor clearance. Enhanced calreticulin exposure and extracellular matrix remodeling underlie this synergy, offering a mechanistic advance for translational immuno-oncology.

• Sabutoclax (SKU A4199): Reliable Pan-Bcl-2 Inhibition in Can

  2026-06-26

  This in-depth article addresses real-world lab challenges in apoptosis, viability, and cytotoxicity assays, demonstrating how Sabutoclax (SKU A4199) delivers quantifiable, reproducible performance as a pan-Bcl-2 inhibitor. Scenario-driven Q&As bridge protocol optimization, data interpretation, and product selection, providing evidence-backed guidance for researchers aiming to improve experimental fidelity and translational relevance.

• Afatinib (BIBW 2992): Irreversible ErbB Tyrosine Kinase Inhi

  2026-06-26

  Afatinib is a potent irreversible inhibitor of EGFR, HER2, and HER4 kinases, widely used in cancer biology research to dissect ErbB-mediated signaling and resistance mechanisms. This article details its mechanism, benchmarks its application in advanced assembloid models, and clarifies best practices for workflow integration.

• SP2509: Lysine-Specific Demethylase 1 Antagonist in AML Rese

  2026-06-25

  SP2509 redefines precision epigenetic modulation in acute myeloid leukemia research by enabling robust, selective disruption of LSD1 activity. Its unique workflow advantages include potent apoptosis induction, facilitation of differentiation, and compatibility with combinatorial epigenetic assays.

• New Selective Nanomolar IRAP Inhibitors via Bestatin Derivat

  2026-06-25

  This study reports the development of α-hydroxy-β-amino acid derivatives of Bestatin with remarkable selectivity and nanomolar potency against insulin-regulated aminopeptidase (IRAP). The findings provide new chemical tools for dissecting M1 zinc aminopeptidase function in immunity and cancer research, with implications for targeted inhibitor design.

• Applied Strategies Using the HyperScribe T7 High Yield Cy3 R

  2026-06-24

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit empowers high-sensitivity, customizable fluorescent RNA probe synthesis for demanding applications such as in situ hybridization and Northern blotting. By optimizing Cy3-UTP incorporation and leveraging robust T7 RNA polymerase transcription, this kit enables precise detection of regulatory RNAs central to sepsis research and beyond.

• Novel FLCN Mutations and mRNA Rescue in Birt-Hogg-Dubé Syndr

  2026-06-23

  This study uncovers two rare FLCN mutations in Chinese Birt-Hogg-Dubé syndrome families and provides the first functional evidence that exogenous FLCN mRNA delivery can restore protein expression and correct mTORC1 signaling defects in vitro. These findings establish a foundational proof-of-concept for mRNA-based therapeutic strategies in BHD and similar loss-of-function genetic disorders.

• Moxidectin Enhances Polyene Activity via Ergosterol Upregula

  2026-06-23

  A recent study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, augments the antifungal efficacy of polyenes against Candida albicans by activating fungal ergosterol biosynthesis. This synergy offers a potential strategy to improve oral candidiasis management, particularly in the context of rising drug resistance and limited antifungal options.

• RG7388 MDM2 Antagonist: Workflows for p53 Pathway Activation

  2026-06-22

  RG7388 (MDM2 antagonist, oral, selective) empowers researchers to drive precise p53 pathway activation and robust cancer cell apoptosis induction, especially in wild-type p53 models. This guide details actionable experimental workflows, synergy with chemoradiation, and troubleshooting strategies for maximizing translational impact with APExBIO’s compound.

• Stattic STAT3 Inhibitor: Applied Workflows in HNSCC Research

  2026-06-22

  Stattic unlocks precise STAT3 pathway interrogation and robust radiosensitization for cancer researchers, with proven efficacy in both in vitro and in vivo HNSCC models. This guide translates recent mechanistic advances into actionable protocols, troubleshooting advice, and comparative context for maximizing Stattic's impact in translational oncology.

• α-Bungarotoxin in Neuroimmune Research: Mechanisms and Innov

  2026-06-21

  Explore how α-Bungarotoxin enables precise nicotinic receptor blockade and advances neuroimmune and placental research. This article reveals new mechanistic insights and assay strategies for cholinergic neurotransmission inhibition.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page